Wound Healing News and Research

RSS

ConvaTec provides support to develop guidelines for NPWT

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today that it has provided support for the development of guidelines for the appropriate use of negative pressure wound therapy in the spectrum of wound healing. Unique to these guidelines are recommendations for integrating NPWT into a comprehensive plan of care that includes moist wound healing dressings and other treatment modalities.

15 Jul 2010

SANUWAVE Health introduces orthoPACE device in Europe

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reports the European launch of the orthoPACE device intended for use in orthopedic, trauma and sports medicine indications following CE mark approval last month.

14 Jul 2010

KCI announces creation of Advanced Research and Technology center

Kinetic Concepts, Inc. announced today the creation of an Advanced Research and Technology (ART) center that will lead the company's efforts to develop revolutionary new wound healing, regenerative medicine, and therapeutic support system technologies and treatments.

13 Jul 2010

New approach of screening drugs that encourage stem cells to repair damaged tissue

Professor Fiona Watt will today (12 July) give the Anne McLaren Memorial Lecture at the UK National Stem Cell Network annual science meeting and will detail a new approach to screening for drugs that target stem cells. To begin with, this is being developed for adult skin stem cells, giving hope for new drugs to promote wound healing and aid the use of stem cells to, for example, treat severe burns. This technique can also be applied to a wide range of stem cells, opening up the possibilities for harnessing stem cells in regenerative medicine.

12 Jul 2010

Derma Sciences submits 510(k) application to FDA for MEDIHONEY Gel Wound & Burn Dressing

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces the achievement of regulatory and commercial milestones.

9 Jul 2010

PhotoMedex receives multi-million dollar order from AMICO Group to purchase XTRAC laser systems

PhotoMedex, Inc. announced that the Company has received from AMICO Group, its distributor in the Middle East, a multi-million dollar order to purchase XTRAC laser systems that will be installed in hospitals throughout the Kingdom of Saudi Arabia. The order includes customary terms and conditions, including advanced payments and letters of credit covering the purchase order. Delivery is expected to be in the third and fourth quarters of this year.

8 Jul 2010

Researchers use nanotechnology to develop advanced wound dressing to detect, treat infection

Researchers are using nanotechnology to develop a medical dressing which will detect and treat infection in wounds. Scientists at the University of Bath and the burns team at the Southwest UK Paediatric Burns Centre at Frenchay Hospital in Bristol are working together with teams across Europe and Australia to create an advanced wound dressing.

8 Jul 2010

Genentech's second Phase III ICON7 study of Avastin in ovarian cancer meets primary endpoint

Genentech, a member of the Roche Group, announced today that a second large, Phase III, international study showed that the combination of Avastin® (bevacizumab) and chemotherapy, followed by the continued use of Avastin alone, increased the time women with previously untreated ovarian cancer lived without the disease worsening (progression-free survival or PFS, the primary endpoint), compared to chemotherapy alone.

2 Jul 2010

Wound Care Innovations signs distribution agreement with KOMED for CellerateRx

Wound Management Technologies, Inc. announced an important milestone in its planned growth strategy. Its wholly owned subsidiary Wound Care Innovations signed a distribution agreement with KOMED, LLC of Georgia for direct response advertising on television and niche online marketing of CellerateRx® in the United States.

1 Jul 2010

Oxycyte PFCE decreases mortality after onset of decompression sickness in porcine model study

Oxygen Biotherapeutics, Inc. today announced that results from U.S. Navy studies demonstrated decreased mortality in porcine animal models that were given an intravenous dose of Oxycyte® perfluorocarbon emulsion (PFCE) after the onset of decompression sickness (DCS). These results showed a statistically significant decrease in mortality compared with the control group that did not receive Oxycyte PFCE. This data was published in the June issue of Aviation Space and Environmental Medicine.

1 Jul 2010

Twelve residents receive one-year fellowship grant to study medical dermatology

Twelve dermatology residents from leading medical schools around the country each received a $40,000, one-year fellowship grant to study medical dermatology. The fellowships, awarded by the National Psoriasis Foundation, provide support to eligible institutions to develop and enhance opportunities for physicians training for careers in medical dermatology.

1 Jul 2010

Biomerix receives FDA 510(k) Clearance to market Ventral Hernia Repair Mesh

Biomerix Corporation announced today that it has received U.S. Food and Drug Administration 510(k) Clearance to market its Biomerix Ventral Hernia Repair Mesh, the latest addition to its innovative portfolio of soft tissue repair devices. The Biomerix Ventral Hernia Repair Mesh, with two distinctly different sides, is the first and only device featuring the Biomerix Biomaterial on one side, designed to promote tissue ingrowth, and a resorbable protective film on the other side, designed to minimize tissue attachment to the device in case of direct contact with the viscera.

1 Jul 2010

Sirnaomics receives NIH SBIR grants to advance siRNA therapeutics for critical human diseases

Sirnaomics, Inc. announced today that the company has received two SBIR (Small Business Innovation Research) grants from National Cancer Institute (NCI) and National Institute of Allergy and Infectious Diseases (NIAID), of National Institute of Health (NIH). Sirnaomics, Inc., a biopharmaceutical company founded in early 2007, is dedicated to developing RNA interference (RNAi) therapeutics for treatment of critical human diseases.

30 Jun 2010

Cancer clues from pregnant lizards

A compound produced by a pregnant lizard may provide important information on the origins and treatment of cancer in humans, according to zoologist Bridget Murphy from the School of Biological Sciences who discovered the protein, which is pivotal to the development of the lizard placenta.

28 Jun 2010

Oxygen' common stock to begin trading on Swiss SIX Exchange

Oxygen Biotherapeutics, Inc. announced today that the company's common stock will begin trading on the Swiss SIX Exchange with the opening of trading tomorrow, Tuesday, June 29, 2010. The company's shares will trade under the same ticker symbol, OXBT, as they currently do on the NASDAQ Capital Market.

28 Jun 2010

Merck challenges New York jury decision in federal FOSAMAX retrial

Merck & Co., Inc. today said it is challenging the decision returned by a New York jury in the retrial of a federal FOSAMAX case, Boles v. Merck. This case was the Plaintiffs' Steering Committee's top choice to take to trial and involved a Florida woman who blamed her dental and jaw problems on FOSAMAX. The first case to reach a verdict, Maley v. Merck, resulted in a defense verdict for Merck on May 5, 2010.

28 Jun 2010

USPTO issues patent related to Derma Sciences' MEDIHONEY Calcium Alginate Dressing

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces that the U.S. Patent and Trademark Office has issued patent No. 7,714,183 related to the Company's MEDIHONEY Calcium Alginate Dressing.

22 Jun 2010

Oxygen Biotherapeutics' common stock approved for secondary listing on SIX Swiss Exchange

Oxygen Biotherapeutics, Inc. announced today that its common stock has been approved for secondary listing on the SIX Swiss Exchange in addition to its listing on the NASDAQ Capital Market. Bank am Bellevue of Zurich is acting as the company's listing agent.

21 Jun 2010

E'shee Clinical Esthetic introduces revolutionary new products for skin care

E'shee Skin Care products are the result of a careful collaboration of skin care professionals, doctors and chemists; these revolutionary new products are the next step in skin care.

19 Jun 2010

LWW sponsors symposium on wound care

The 25th Anniversary Clinical Symposium on Advances in Skin & Wound Care: The Conference for Prevention and Healing will be held September 30-October 3, 2010, at the Gaylord Palms Hotel and Convention Center in Kissimee, FL. The symposium is sponsored by Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

17 Jun 2010

Wound Healing News and Research

ConvaTec provides support to develop guidelines for NPWT

SANUWAVE Health introduces orthoPACE device in Europe

KCI announces creation of Advanced Research and Technology center

New approach of screening drugs that encourage stem cells to repair damaged tissue

Derma Sciences submits 510(k) application to FDA for MEDIHONEY Gel Wound & Burn Dressing

PhotoMedex receives multi-million dollar order from AMICO Group to purchase XTRAC laser systems

Researchers use nanotechnology to develop advanced wound dressing to detect, treat infection

Genentech's second Phase III ICON7 study of Avastin in ovarian cancer meets primary endpoint

Wound Care Innovations signs distribution agreement with KOMED for CellerateRx

Oxycyte PFCE decreases mortality after onset of decompression sickness in porcine model study

Twelve residents receive one-year fellowship grant to study medical dermatology

Biomerix receives FDA 510(k) Clearance to market Ventral Hernia Repair Mesh

Sirnaomics receives NIH SBIR grants to advance siRNA therapeutics for critical human diseases

Cancer clues from pregnant lizards

Oxygen' common stock to begin trading on Swiss SIX Exchange

Merck challenges New York jury decision in federal FOSAMAX retrial

USPTO issues patent related to Derma Sciences' MEDIHONEY Calcium Alginate Dressing

Oxygen Biotherapeutics' common stock approved for secondary listing on SIX Swiss Exchange

E'shee Clinical Esthetic introduces revolutionary new products for skin care

LWW sponsors symposium on wound care

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News